Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Journal of Diabetes Science and Technology|February 23, 2022
A Long-Term Evaluation of Facebook for Recruitment and Retention in the ENDIA Type 1 Diabetes Pregnancy-Birth Cohort StudyKelly J McGorm, James D Brown, Rebecca L Thomson, et al.
Frontiers in Clinical Diabetes and Healthcare|November 29, 2024
Parental experiences of using continuous glucose monitoring in their young children with early-stage type 1 diabetes: a qualitative interview studyAlison G Roberts, Alexandra S Tully, Sabrina K Binkowski, et al.
Children (Basel, Switzerland)|May 16, 2023
Experiences of Caregivers and At-Risk Children Enrolled in a Prospective Pregnancy-Birth Cohort Study into the Causes of Type 1 Diabetes: The ENDIA StudyKelly J McGorm, James D Brown, Alison G Roberts, et al.
Diabetologia|August 8, 2025
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiomeAlexandra J Roth-Schulze, Esther Bandala-Sanchez, Katrina M Ngui, et al.
Diabetologia|September 2, 2024
Dietary patterns during pregnancy and maternal and birth outcomes in women with type 1 diabetes: the Environmental Determinants of Islet Autoimmunity (ENDIA) studyRebecca L Thomson, James D Brown, Helena Oakey, et al.
Diabetes Care|February 2, 2022
Mental Health During Late Pregnancy and Postpartum in Mothers With and Without Type 1 Diabetes: The ENDIA StudyMadeleine Hall, Helena Oakey, Megan A S Penno, et al.
Diabetes Care|January 16, 2026
A Comparison of Diet and Exercise During Pregnancy in Women With and Without Type 1 Diabetes Followed in the Environmental Determinants of Islet Autoimmunity (ENDIA) StudyRebecca L Thomson, Guinevere Martin, James D Brown, et al.
Nature Communications|December 3, 2025
Indigenous infants in remote Australia retain an ancestral gut microbiome despite encroaching WesternizationLeonard C Harrison, Theo R Allnutt, Sarah Hanieh, et al.
Contemporary Clinical Trials|November 20, 2019
A physician-initiated double-blind, randomised, placebo-controlled, phase 2 study evaluating the efficacy and safety of inhibition of NADPH oxidase with the first-in-class Nox-1/4 inhibitor, GKT137831, in adults with type 1 diabetes and persistently elevated urinary albumin excretion: Protocol and statistical considerationsAnne T Reutens, Karin Jandeleit-Dahm, Merlin Thomas, et al.
Pediatric Diabetes|May 21, 2020
Changes in pancreatic exocrine function in young at-risk children followed to islet autoimmunity and type 1 diabetes in the ENDIA studyMegan A S Penno, Helena Oakey, Priya Augustine, et al.
Pageof 6